{"id":1951,"date":"2024-09-11T20:14:18","date_gmt":"2024-09-11T20:14:18","guid":{"rendered":"https:\/\/onltherapeutics.com\/test\/?page_id=1951"},"modified":"2025-12-04T14:31:06","modified_gmt":"2025-12-04T14:31:06","slug":"board_michelle-ma-phd","status":"publish","type":"page","link":"https:\/\/onltherapeutics.com\/test\/board_michelle-ma-phd\/","title":{"rendered":"Board_Michelle Ma, PhD"},"content":{"rendered":"\n
\n
\n

Michelle Ma, PhD<\/h3>\n\n\n\n

Board Observer<\/p>\n<\/div>\n<\/div>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

Dr. Michelle Ma is an associate at the Novartis Venture Fund (NVF) in Cambridge, Massachusetts. Prior to joining NVF, she worked in the lab of Eric Fischer and her thesis focused on elucidating novel mechanisms of degraders with biochemistry and structural biology. Michelle holds a BA in molecular and cell biology from UC Berkeley and a PhD in biochemistry from Harvard University.<\/p>\n\n\n\n

<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
Back to Our Board<\/a><\/div>\n<\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n","protected":false},"excerpt":{"rendered":"

Michelle Ma, PhD Board Observer Dr. Michelle Ma is an associate at the Novartis Venture Fund (NVF) in Cambridge, Massachusetts. Prior to joining NVF, she worked in the lab of Eric Fischer and her thesis focused on elucidating novel mechanisms of degraders with biochemistry and structural biology. Michelle holds a BA in molecular and cell […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"blank","meta":{"ngg_post_thumbnail":0,"footnotes":""},"class_list":["post-1951","page","type-page","status-publish","hentry"],"featured_image_urls_v2":{"full":"","thumbnail":"","medium":"","medium_large":"","large":"","1536x1536":"","2048x2048":"","gform-image-choice-sm":"","gform-image-choice-md":"","gform-image-choice-lg":""},"post_excerpt_stackable_v2":"

Michelle Ma, PhD Board Observer Dr. Michelle Ma is an associate at the Novartis Venture Fund (NVF) in Cambridge, Massachusetts. Prior to joining NVF, she worked in the lab of Eric Fischer and her thesis focused on elucidating novel mechanisms of degraders with biochemistry and structural biology. Michelle holds a BA in molecular and cell biology from UC Berkeley and a PhD in biochemistry from Harvard University. Back to Our Board<\/p>\n","category_list_v2":"","author_info_v2":{"name":"theo@myriadweb.com","url":"https:\/\/onltherapeutics.com\/test\/author\/theomyriadweb-com\/"},"comments_num_v2":"0 comments","_links":{"self":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1951","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/comments?post=1951"}],"version-history":[{"count":7,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1951\/revisions"}],"predecessor-version":[{"id":2634,"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/pages\/1951\/revisions\/2634"}],"wp:attachment":[{"href":"https:\/\/onltherapeutics.com\/test\/wp-json\/wp\/v2\/media?parent=1951"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}